Genetic therapy for the nervous system: A tendency in modern neurology;La terapia genetica para el sistema nervioso: Una tendencia en la neurologia moderna

Revista de Neurologia

Volumn 27, Issue 158, 1998, Pages 625-630

  Gonzalez Hoyuela M ^a  

^a CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

Author keywords

Genetic therapy; Neurodegenerative diseases; Neurotrophic factors

Indexed keywords

ALZHEIMER DISEASE; GENE TECHNOLOGY; GENE THERAPY; GENE TRANSFER; HUMAN; NEUROLOGIC DISEASE; NEUROLOGY; PARKINSON DISEASE; REVIEW; ANIMAL; CELL CULTURE; GENETIC TRANSFECTION; METHODOLOGY;

ANIMALS; CELLS, CULTURED; GENE THERAPY; HUMANS; NERVOUS SYSTEM DISEASES; NEUROLOGY; TRANSFECTION;

EID: 0031728151     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.27158.98083     Document Type: Review

References (30)

1. Gage FH, Wolff JA, Rosemberg MB, et al. Grafting genetically modified cell to the brain: possibilities for the future. Neurosciencc 1987; 23: 795-807.
2. Friedmann T. Progress toward human gene therapy. Science 1989; 244: 1275-81.
3. Verma YM. Gene therapy. Sci Am 1990; 263: 68-72, 81-4.
4. Miller AD. Human gene therapy come of age. Nature 1992; 357: 455-60.
5. Anderson WF. Human gene therapy. Science 1992; 256: 808-13.
6. Mulligan RC. The basic science of gene therapy. Science 1993; 260: 926-32.
7. Soriano P, Friedrich G, Lawinger P. Promoter interactions in retrovirus vector introduced into fibroblasts and embryonic stem cells. J Virol 1991; 65: 2314-9.
8. Wolff JA, Fisher LJ, Xu L, et al. Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease. Proc Natl Acad Sci USA 1989; 86: 901-904
9. Fisher LJ, Jinnah HA, Kale LC, Higgin GA, Gage FH. Survival and function of intrastrial grafted primary fibroblast to produce L-dopa. Neuron 1991; 6: 371-80.
10. Andreason GL, Evans GA. Optimization of electroporation for transfcction of mammalian cells eines. Anal Biochem 1989; 180: 269-75.
11. Chen CA, Okayama H. Calcium phosphate mediated gene transfer: a highly efficient transfection system for stable transforming cells with plasmid DNA. Biotechniques 1988; 6: 632-8.
12. Felgner PL, Gadek TR, Holm M, et al. Lipofectine: a highly efficient lipid mediated DNA transfer procedure. Proc Natl Acad Sci USA 1987; 84: 7413-7.
13. Feigner PL, Holm M. Cationic liposome mediated transfection. Focus 1989; 11: 21-5.
14. Ray J, Gage FH. Gene transfer into established and primary fibroblast cell lines: comparison of transfection methods and promoters. Biotechniques 1992; 13: 598-603.
15. Kilpatrick TJ, Barlett P. Cloning and growth of multipotential neuronal precursors: requirements for proliferation and differentiation. Neuron 1993; 10: 255-65.
16. Horcllou P, Marlier L, Privat A, et al. Exogenous expression of Ldopa and dopamine in various cell lines following transfer of rat and human tyrosine hydroxilase cDNA: grafting in an animal model of Parkinson's disease. Prog Brain Res 1990; 82: 23-32.
17. Espinosa de los Monteras A, Zhang M, de Vellis J. O2A progenitor cells transplanted into the neonatal rat brain develop into oligodendrocytes but not astrocytes. Proc Natl Acad Sci USA 1993; 90: 50-4.
18. Shimohama S, Rosemberg M, Fagan AM, et al. Grafting genetically modified cells into the rat brain: characteristic of E. coli galactosidasc as a reporter gene. Brain Res Mol Brain Res 1989; 5: 271-8.
19. Uchida K, Takamatsu K, Kaneda N, et al. Synthesis of L 3,4 dihydroxyphenylalanineby tyrosine hydroxilase cDNA transfccted C6 cells, application for intraccrebral grafting. J Neurochem 1989; 53: 728-33.
20. Ronnet GV, Hester LD, Nye JS, Connors K, Snyder SD. Human cortical neuronal cell line: establishment from a patient with unilateral megalencephaly. Science 1990; 248: 603-5.
21. Ryder EF, Snyder EY, Dcitcher DL, Walsh C, Amold-Aldea R, Hartwieg EA, et al. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 1992; 68: 33-51.
22. Jiao S, Schultz E, Wolff J. Intracerebral trasplants of primary muscle cells: a potential platform for transgene expression in the brain. Brain Res 1992; 575: 143-7.
23. Jiao S, Gurcvich V, WolfT JA. Long tenn correction of rat model of Parkinsons disease by gene therapy. Nature 1993; 362: 450-3.
24. Jiao S, William P, Berg RK, et al. Direct gene transfer into non human primate myofiber in vivo. Hum Gene Ther 1992; 3: 21-3.
25. Horellou P, Brundin P, Mallet J, Bjorklund A. In vivo release of dopa and dopamine from genetically engineered cells grafted to denervated rat striatum. Neuron 1990; 5: 393-402.
26. Kawaja MD, Fisher LJ, Schintine M. Grafting genetically modified cells within the rat central nervous system: methodological consideration. In Dunnet SB, Bjorklund A, cds. Neural transplantation: a practical approach. New York: Oxford University; 1996.
27. Gage FH, Kawaja MD, Fisher LJ. Genetically modified cells: applications for intracerebral grafting. Trend Ncurosci 1991; 14: 328-33.
28. Picardo P, Maysinger D, Cuello AC. Recovery of nucleus basalis cholinergic neurons by grafting NGF secretor fibroblast. Neuroreport 1992; 3: 353-6.
29. Kawaja MD, Fagan AM, Firestein BL, Gage FH. Intracerebral grafting of cultured autologous skin fibroblasts into the rat striatum: an assessment of graf size and ultrastructurc. J Com Neurol 1991; 307: 695-706.
30. Breakefield XO, de Luca NA. Herpes simplex virus for gene delivery to neurons. New Biol 1991; 3: 203-18.